We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Prospective Multi Centre Trial on Bipolar Radiofrequency Ablation of Atrial Fibrillation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00184249
Recruitment Status : Withdrawn (Collaborators did not enter patients into the study)
First Posted : September 16, 2005
Last Update Posted : March 20, 2015
Sponsor:
Collaborators:
St. Olavs Hospital
Oslo University Hospital
Haukeland Sykehus HF
Ullevaal University Hospital
Regionssykehuset i Tromsø HF
Feiringklinikken
Information provided by (Responsible Party):
Norwegian University of Science and Technology

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The study is a prospective multi-centre study to investigate the effect of a new bipolar ablation strategy of the left atrium in patients with paroxysmal or permanent atrial fibrillation over time.

Condition or disease Intervention/treatment Phase
Atrial Fibrillation Procedure: Bipolar radiofrequency ablation Not Applicable

Detailed Description:

Atrial fibrillation (AF) is the most common persistent arrhythmia, prevalent in about 6% of the population over 65 years of age. AF reduces the quality of life and increases mortality. AF is particularly common in combination with mitral valve disease, but is also detected in about 5% of patients with aortic valve and coronary artery disease. Surgical treatment of AF with the Cox-maze III operation was developed by J. Cox during the 80ies. The aim of the operation is to block spread of irregular electrical activity by creating lines of isolation in the atrial musculature. The operation achieves sinus rhythm in over 90% in selected patients. Nevertheless the method was only used in few heart surgical centres, because it is complex and time consuming.In recent years alternative energy sources have been developed to create isolating lines without cutting the tissue and thus making ablation treatment easier. Bipolar radiofrequency ablation is special because the energy is delivered feedback controlled until transmurality is achieved. This is a prerequisite for a good result and makes using the equipment safer.

Since the development of the Cox-maze procedure, our knowledge of atrial fibrillation and its treatment has increased considerably. There is a consensus that the posterior part of the left atrium and in particular the pulmonary veins are an important target for treatment. Surgical ablation with alternative energy sources is a new method under continued development and evaluation.

The optimal ablation treatment is unknown. A balance between invasiveness and achieving sinus rhythm in as many as possible has to be found. Creating numerous ablation lines in both atria is time consuming and leads probably to an increased need for permanent pacemaker implantation and reduced contractility of the atrial tissue. On the other hand can a simple bipolar ablation of pulmonary veins performed easily, but this is probably an insufficient treatment for most patients. In the protocol a new method using solely bipolar ablation for creation of several ablation lines in the left atrium is described.

The study is a prospective multi-centre study to investigate the effect of a new bipolar ablation strategy of the left atrium in patients with paroxysmal or permanent AF over time.

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 0 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Prospective Multi Centre Trial on Bipolar Radiofrequency Ablation of Atrial Fibrillation
Study Start Date : June 2005
Actual Primary Completion Date : June 2010
Actual Study Completion Date : June 2012

Resource links provided by the National Library of Medicine


Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: Bipolar radiofrequency ablation Procedure: Bipolar radiofrequency ablation
Ablation using CE marked bipolar ablation devices
Other Names:
  • Cardioblade
  • Atricure


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Number of patients in sinus rhythm after 3, 6, and 12 months [ Time Frame: 3, 6, ]
  2. Number of patients with atrial function at echo-doppler after 6 and 12 months [ Time Frame: 3,6, 12 months ]
  3. Number of patients on anticoagulants after 6 and 12 months [ Time Frame: 6 and 12 months ]

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • referred for elective heart surgery with extracorporeal circulation
  • suffers from AF for more than 6 months but less than 7 years
  • aged between 18 and 80 years
  • ejection fraction above 30 %

Exclusion Criteria:

  • Reoperations
  • NYHA class IV
  • Ischemic mitral incompetence
  • Creatinine > 140
  • Transmural myocardial infarction < 4 weeks
  • Endocarditis
  • Serious peripheral vascular disease
  • Pregnancy or breast-feeding
  • Drug addiction
  • Size of left atrium > 60 mm in preoperative echo-doppler investigation.
  • Disease or other condition when the patient is unable to understand the objectives and the scope of the study.
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00184249


Sponsors and Collaborators
Norwegian University of Science and Technology
St. Olavs Hospital
Oslo University Hospital
Haukeland Sykehus HF
Ullevaal University Hospital
Regionssykehuset i Tromsø HF
Feiringklinikken
Investigators
Layout table for investigator information
Study Director: Alexander Wahba, Prof Norwegian University of Science and Technology
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT00184249    
Other Study ID Numbers: 120905
First Posted: September 16, 2005    Key Record Dates
Last Update Posted: March 20, 2015
Last Verified: March 2015
Keywords provided by Norwegian University of Science and Technology:
Catheter ablation
Heart/surgery
Cardial surgical procedures
Additional relevant MeSH terms:
Layout table for MeSH terms
Atrial Fibrillation
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Pathologic Processes